![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 19, 16682-16688, May 10, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, February 5, 2002
Thiol-disulfide oxidoreductases are required for
disulfide bond formation in proteins that are exported from the
cytoplasm. Four enzymes of this type, termed BdbA, BdbB, BdbC, and
BdbD, have been identified in the Gram-positive eubacterium
Bacillus subtilis. BdbC and BdbD have been shown to be
critical for the folding of a protein required for DNA uptake during
natural competence. In contrast, no function has been assigned so far
to the BdbA and BdbB proteins. The bdbA and
bdbB genes are located in one operon that also contains the
genes specifying the lantibiotic sublancin 168 and the ATP-binding
cassette transporter SunT. Interestingly sublancin 168 contains
two disulfide bonds. The present studies demonstrate that SunT and
BdbB, but not BdbA, are required for the production of active sublancin
168. In addition, the BdbB paralogue BdbC is at least partly able to
replace BdbB in sublancin 168 production. These observations show the
unprecedented involvement of thiol-disulfide oxidoreductases in the
synthesis of a peptide antibiotic. Notably BdbB cannot complement BdbC
in competence development, showing that these two closely related
thiol-disulfide oxidoreductases have different, but partly overlapping,
substrate specificities.
Bacillus subtilis is a Gram-positive soil bacterium
that is particularly well known for its high protein secretion
potential (1, 2). A small group of secreted Bacillus
proteins is formed by lantibiotics, small post-translationally modified
peptides that exhibit antimicrobial activity (3-5). In general,
lantibiotics are characterized by the presence of the unusual amino
acids 2,3-didehydroalanine and/or 2,3-didehydrobutyrine, which are
formed by dehydration of serine and threonine residues, respectively
(6). With neighboring cysteine residues they can form a lanthionine
(2,3-didehydroalanine) or 3-methyllanthionine bridge
(2,3-didehydrobutyrine). To date two lantibiotics of B. subtilis have been characterized in detail. These are subtilin
from B. subtilis ATCC 6633 (7, 8) and sublancin 168 from
B. subtilis 168 (9). In addition, two lantibiotic-like peptides originating from the ericin gene cluster of B. subtilis A1/3 were recently described (10). Notably sublancin 168 displays the extraordinary characteristic of having two disulfide bonds in addition to a Sublancin 168, specified by sunA, was identified as a type
AII lantibiotic by Paik et al. (9) in 1998. Presumably it
acts by forming pores in the cytoplasmic membrane of a sensitive
organism (11). Type AII lantibiotics are characterized by a "double
glycine" GG, GA, or GS motif in their leader sequence, GS in
sublancin 168, which is preceded by conserved EL or EV and EL or EM
sequences. Cleavage occurs immediately behind the double glycine motif
during transport by a dual-function transporter that also has leader peptidase activity. The leader is thought to prevent the lantibiotic from becoming active before translocation (12, 13). The sunT gene, which is located directly downstream of sunA, encodes
a protein possessing features of a dual-function ATP-binding cassette transporter with a proteolytic domain and an ATP-binding cassette. These domains are common among lantibiotic transporters (3).
Interestingly the sublancin 168 operon appears to include the
bdbA and bdbB genes (bdb for
Bacillus disulfide bond) downstream of sunT (Fig. 2). The corresponding BdbA and BdbB
proteins were previously identified by Bolhuis et al. (14)
and have been implicated in thiol-disulfide redox reactions. BdbA shows
sequence similarity to the thiol-disulfide oxidoreductase Bdb of
Bacillus brevis (15, 16), whereas BdbB shows significant
sequence similarity to DsbB of Escherichia coli (15 ,17).
BdbB was shown to be involved in the folding of PhoA of E. coli upon the expression of this secretory protein in B. subtilis. As PhoA contains two disulfide bonds, this indicates
that BdbB is involved in disulfide bond formation. However, compared
with its paralogue BdbC, BdbB was less important for the folding of
PhoA (15). These observations prompted us to investigate whether BdbA,
BdbB, and BdbC have a role in the production of functional sublancin
168 in particular because this lantibiotic contains two disulfide
bonds. The present results show that BdbB and BdbC are involved in the
production of active sublancin 168, whereas BdbA is not required. The
finding that thiol-disulfide oxidoreductases are required for the
synthesis of a peptide antibiotic has never been
reported.
Plasmids, Bacterial Strains, and Growth Conditions--
Table
I lists the plasmids and strains used. TY
medium contained Bacto tryptone (1%), Bacto yeast extract (0.5%), and
NaCl (0.5%). Antibiotics were used in the following concentrations: ampicillin, 100 µg/ml; chloramphenicol, 5 µg/ml; erythromycin, 2 µg/ml; and kanamycin, 10 µg/ml. Xylose was used at 1% (w/v) concentrations.
DNA Techniques--
Procedures for DNA purification,
restriction, ligation, agarose gel electrophoresis, and transformation
of competent E. coli DH5
To construct B. subtilis
To construct B. subtilis
To construct B. subtilis bdbB-XbdbB, the
bdbB gene was amplified using the primers yolK1 (CTC CAC
tcT Aga GAA CAC GTC CTG AAA GGA ATT GAA GTA TG) and yolKm2
(cgg att acc gga tcc tca gtt cag gtc ctc ctc gct gat aag
ttt ttg ttc ATT ATA TAC ATG TTG ATT TTG TTT T). The amplified fragment
was ligated into plasmid pX downstream of the xylA promoter.
This vector was integrated into the amyE locus of B. subtilis bdbB by double crossover recombination resulting in the
strain B. subtilis bdbB-XbdbB.
To construct B. subtilis
bdbC-Km,1 first a pUC18
construct containing the bdbC gene was made. Primers yvgU1
(GAA ATt ctA GAG ACA ATA GAA AAA GAG CTG AAA GGG AAG TAA C)
and yvgU3 (GCG CCC GGg ATc CGC GGG CGC TTT TTT TGT TAT TCA
GAT TTT TCG CCT TTC AGC AGG CAC) were used to amplify the
bdbC gene. This fragment was ligated into the multiple
cloning site of pUC18 resulting in pUC18bdbC. The
NsiI site within the bdbC gene was then used to
insert a KmR marker that was isolated from pKM1 (laboratory
collection; Jan Kiel) using HincII. In this way pUC18bdbCKm
was obtained, and this plasmid was subsequently used to transform
B. subtilis 168. A double crossover event then led to
B. subtilis bdbC-Km in which the bdbC gene is
disrupted by the KmR cassette. Correct integration was
verified using Southern hybridization. To construct the double mutant
B. subtilis bdbB bdbC-Km, the B. subtilis bdbB
strain was transformed with chromosomal DNA of B. subtilis
bdbC-Km.
Sublancin 168 Activity Assay--
A halo assay was performed on
plates with B. subtilis Delayed Extraction-Matrix-assisted Laser Desorption
Ionization-Time of Flight Mass Spectra
(DE-MALDI-TOFMS)--
DE-MALDI-TOFMS were recorded on a
Voyager-RP-DE instrument (PerSeptive Biosystems) using a 337 nm
nitrogen laser for desorption and ionization. All experiments were
carried out with the linear positive ion mode. The total acceleration
voltage was 25 kV; 23.6 kV was used on the first grid. The delay time
was 250 ns. 1-ml aliquots of culture supernatants and media were
extracted with 200 µl of 1-butanol. 150 µl of the butanolic phase
was dried in a Speed-Vac evaporator, and extracted peptides were
dissolved in 20 µl of solvent A (0.1% trifluoroacetic acid, 20%
acetonitrile in water (v/v)) and adsorbed to 1 µl of POROS 50 R2
(PerSeptive) beads prepared as a microcolumn as described by Kussmann
et al. (24). After washing with 20 µl of solvent A, the
peptides were eluted with 4 µl of a mixture of 70% acetonitrile,
0.1% trifluoroacetic acid in water (v/v). Sample preparation for MALDI
was performed with the solution phase nitrocellulose method described
by Landry et al. (25). Between 100 and 250 single scans were
accumulated for each mass spectrum.
Sequence Similarity Searches and Prediction of Transmembrane
Regions--
Similarity searches were performed with the standard
protein-protein BLAST algorithm (www.ncbi.nlm.nih.gov/BLAST/) at NCBI (26) using Swiss-Prot as the data base. Transmembrane segments in SunT
were predicted using the TMHMM algorithm version 2.0 (www.cbs.dtu.dk/services/TMHMM-2.0/) from the Center for
Biological Sequence Analysis (CBS) (27).
SunT Is Required for Sublancin 168 Production--
As a first
approach to characterize the factors involved in the production of
sublancin 168, the production of this lantibiotic by a sunT
mutant strain was tested. It has to be noted that the sunT
strain contains a pMutin2 disruption in the 3' end of sunT, placing the downstream bdbA, yolJ, and
bdbB genes under the control of the
isopropyl-1-thio- BdbB Has a Major Role in Sublancin 168 Production--
To
investigate whether BdbB is involved in the production of sublancin
168, the halo assay with the BdbC Can Partly Replace BdbB--
The residual activity of
sublancin 168 upon disruption of the bdbB gene suggested
that another protein was at least partly able to fulfill the role of
BdbB. Especially BdbC was a likely candidate because of its high degree
of sequence similarity with BdbB (15). Therefore, the possible effect
of a bdbC disruption on sublancin production was tested. In
contrast to the bdbB mutant, the bdbC mutant
produced sublancin 168 at levels that were comparable to those produced
by the parental strain (Fig. 6). However,
the strain with the bdbB and bdbC genes both
disrupted did not display any sublancin 168 activity. This leads to the
conclusion that BdbC is not required for production of sublancin 168 when BdbB is present. Nevertheless, BdbC can partly replace BdbB in the absence of the latter.
BdbA Is Not Required for Sublancin 168 Production--
To
investigate the role of BdbA in sublancin 168 production a strain with
a clean bdbA deletion was constructed and subsequently tested for sublancin 168 production. This strain did not show any
sublancin 168 activity (Fig. 7). However,
also when this strain was provided with a bdbA gene that was
ectopically expressed from a xylose-inducible promoter, sublancin 168 production was not restored (data not shown). This indicated that
bdbA, unlike sunT, is not essential for this
process. As shown in Fig. 3, the sunT and bdbA
genes are partially overlapping. Thus, the 3' end of the
sunT gene might have been damaged during the construction of
the clean bdbA deletion strain. Alternatively the deletion of bdbA might interfere with the expression of its
downstream genes resulting in reduced levels of active sublancin 168. Therefore, a pMutin2-based integration plasmid containing the 3' end of
sunT was constructed. Upon a Campbell-type integration of
this plasmid (pMsunTrec), the 3' end of sunT was replaced
with the experimentally verified correct sequence. Simultaneously the
downstream genes of bdbA were placed under the control of
the Pspac promoter. Subsequently we determined
whether sublancin 168 activity in the resulting strain
Subtilosin Production Is Not Affected in bdb Mutants--
In
addition to sublancin 168, another bacteriocin of B. subtilis 168 is known for which the presence of a disulfide bond
has been proposed initially: subtilosin (28). Subtilosin (29) is
composed of 35 amino acids, including three cysteines. Despite the
presence of these cysteines, a recent structural analysis of subtilosin
by two-dimensional 1H NMR provided no evidence for
disulfide bond formation in this bacteriocin (30). To investigate
whether the Bdb proteins might, nevertheless, be involved in the
synthesis of subtilosin, DE-MALDI-TOF mass spectrometric analyses were
performed. Notably this allowed the parallel monitoring of the presence
of both subtilosin and sublancin 168 in supernatants of bdb
mutant strains. As shown in Fig. 8,
subtilosin was identified by its proton-adduct at
m/z 3403.3 (average mass; Ref. 30). The presence
of sublancin 168 is indicated by a signal at m/z
3881.2 (average mass), which is in good accordance with
m/z 3877.8 observed for purified sublancin (Ref.
9; data not shown). The data demonstrate that subtilosin production is
not affected in the bdb mutant. Furthermore, the mass
spectrometry results concerning sublancin 168 are in accord with the
results from the halo assays. Interestingly supplementation of the
medium with xylose leads to the appearance of additional signals with
appreciably higher masses (+132 and +264 Da) than observed in
medium without xylose. This observation can be interpreted with a
covalent modification of subtilosin and sublancin 168, suggesting that
both bacteriocins are modified under these conditions. In conclusion,
the present observations show that SunT and BdbB are major determinants
for the production of sublancin 168, whereas the production of
subtilosin does not depend on these proteins.
In this report we show for the first time that the presence of at
least one thiol-disulfide oxidoreductase, BdbB or BdbC, is required for
the production of active sublancin 168. Notably BdbB is of major
importance for this process, whereas the involvement of BdbC is only
evident in the absence of BdbB. Whether BdbB and BdbC are directly or
indirectly involved in sublancin 168 production has yet to be
determined. The presence of two disulfide bonds in this lantibiotic
makes it conceivable that BdbB and BdbC are directly involved in its
folding. However, alternative indirect effects on sublancin 168 folding
or maturation cannot be excluded. For example, it is conceivable that
BdbB and BdbC act on SunT because this protein contains 10 cysteine
residues. SunT belongs to a large family of ATP-binding cassette
transporters involved in the processing and export of lantibiotics and
other bacteriocins (31). Consistently our present findings show that
SunT is required for the production of sublancin 168. Although most
ATP-binding cassette transporters appear to contain six transmembrane
segments, the bacteriocin transporters are generally characterized by
four transmembrane domains (32). In addition, these transporters have a
carboxyl-terminal ATP-binding site (33), which is located in the
cytoplasm. Specifically SunT shows a high level of sequence similarity
to MesD of Leuconostoc mesenteroides (34) and LcnC of
Lactococcus lactis (35), the transporters for mesentericin Y105 and lactococcin A, respectively. For LcnC a detailed topology analysis was performed by Franke et al. (36) indicating that this protein has four transmembrane segments. Computer-assisted predictions suggest that SunT, like LcnC, contains four transmembrane sequences, an amino-terminal cytoplasmic peptidase domain (36), and one
carboxyl-terminal ATP-binding domain. A fifth hydrophobic domain, which
is conserved in LcnC, is probably not spanning the membrane as this
would localize the ATP-binding domain at the extracytoplasmic side of
the membrane (Fig. 9). Importantly all 10 cysteine residues of SunT have a predicted cytoplasmic localization, which makes them unlikely substrates for BdbB or BdbC, the catalytic domains of which are localized at the extracytoplasmic side of the
membrane (15). Consequently an indirect influence of BdbB or BdbC via
SunT on sublancin 168 appears to be unlikely.
Apart from the fact that the SP Although the bdbA gene partly overlaps with the upstream
sunT gene, the deletion of this gene in the
The fact that subtilosin production is not affected in the mutants
studied is fully consistent with the recently published structure of
this peptide antibiotic (30). According to this model, subtilosin has
three inter-residue bridges in which its cysteine residues are
involved. Two cysteines are linked with phenylalanine residues, and one
is linked with a threonine. This raises the intriguing question of how
subtilosin molecules escape from disulfide bond formation during their
export in contrast to sublancin 168 molecules.
Strikingly, both for subtilosin and sublancin 168, molecule species
were observed with increased molecular mass when B. subtilis bdbB-XbdbB was grown in the presence of 1% xylose.
This unprecedented finding shows that subtilosin as well as sublancin
168 can undergo growth medium-dependent modifications.
Based on the observed mass increases, it is possible that subtilosin
has one xylose adduct (+132 Da), whereas sublancin 168 has either one
(+132 Da) or two (+264 Da) of these adducts. Notably Paik et
al. (9) have previously reported a modification of sublancin 168 that increases its mass with 164.48 Da. The precise nature of these
modifications and their effect on bactericidal activity remain to be elucidated.
In conclusion, the present observations show for the first time an
involvement of thiol-disulfide oxidoreductases in the production of a
peptide antibiotic. Furthermore, our results reveal an important function of the BdbB and BdbC proteins in the B. subtilis
cell. Thus far the BdbB protein was only known to be involved in the folding of the heterologous secretory protein PhoA, whereas BdbC was
shown to be required for competence development in addition to the
secretion of the heterologous protein PhoA (15, 42). Our ongoing
research is focused on the identification of the determinants for the
substrate specificities of the thiol-disulfide oxidoreductases of
B. subtilis, BdbB and BdbC in particular. For this purpose, it will be of major importance to answer the question of whether BdbB
is directly or indirectly involved in the formation of the disulfide
bonds of sublancin 168.
We thank Jean-Yves Dubois, Karl-Dieter
Entian, S. Dusko Ehrlich, Caroline Eschevins, Rob Meima, and
members of the Groningen and European Bacillus Secretion
Groups for valuable discussions. Furthermore, we greatly acknowledge
Michael Karas, University of Frankfurt, for the opportunity to use the
PerSeptive MALDI-TOF mass spectrometric equipment.
*
Funding for the project, of which this work is a part, was
provided by the Commission of the European Union Projects
BIO4-CT98-0250, QLK3-CT-1999-00413, and QLK3-CT-1999-00917.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
Present address: Dept. of Biological Sciences, University of
Warwick, Coventry CV4 7AL, United Kingdom.
Published, JBC Papers in Press, February 28, 2002, DOI 10.1074/jbc.M201158200
The abbreviations used are:
Km, kanamycin;
DE-MALDI-TOFMS, delayed extraction-matrix-assisted laser desorption
ionization-time of flight mass spectra.
Thiol-Disulfide Oxidoreductases Are Essential for the Production
of the Lantibiotic Sublancin 168*
,
,
**,
,

, and
Department of Pharmaceutical Biology,
University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the
Netherlands, the § Institut für Mikrobiologie, J. W. Goethe Universität, Marie-Curie-Str. 9, 60439 Frankfurt am
Main, Germany, ¶ Génétique Microbienne, Institut
National de la Recherche Agronomique-Domaine de Vilvert,
78352 Jouy en Josas cedex, France, and the
Department of
Genetics, University of Groningen, Kerklaan 30, PO Box 14, 9750 AA
Haren, the Netherlands
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-methyllanthionine bridge (Fig. 1).

View larger version (8K):
[in a new window]
Fig. 1.
Schematic representation of the lantibiotic
sublancin 168 as proposed by Paik et al. (9). C,
carboxyl terminus; N, amino terminus; S-S,
disulfide bond; L, lanthionine bridge.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Plasmids and bacterial strains
cells were carried out as
described by Sambrook et al. (18). Enzymes were from
Invitrogen. B. subtilis was transformed as described by
Kunst and Rapoport (19). The nucleotide sequences of primers (5'-3')
used for PCR are listed below; nucleotides identical to genomic
template DNA are printed in capital letters, restriction sites used for
cloning are underlined, and nucleotides used for PCR-mediated coupling
are in bold.
![]()
View larger version (5K):
[in a new window]
Fig. 2.
Schematic representation of the sublancin 168 operon. Relative locations of the sun genes for
sublancin 168 (sunA) and sublancin 168 transport
(sunT), the genes specifying the thiol-disulfide
oxidoreductases bdbA and bdbB, and the gene of
unknown function, yolJ, are indicated. The distances between
the genes are: sunA-sunT, 60 nucleotides;
sunT-bdbA, 4 nucleotides overlap;
bdbA-yolJ, 2 nucleotides;
yolJ-bdbB, 1 nucleotide overlaps.
bdbA, splicing by
overlap extension (20) was used. Two fragments flanking the
bdbA gene were amplified and ligated into the chromosomal
integration and excision plasmid pORI280 (21) after PCR-mediated
coupling or ligation. The upstream fragment bdbAfr of 811 nucleotides was amplified using the primers bdbAfr1 (GCA ATC
AGA TCT TCA GCA GGC AC) and bdbAfr2 (gtt
tca tac tag tta gct aat taa tca TAT AGA ATA CTC CTT
ATT TTC CGA GTA GCT CG). The downstream fragment bdbAbk of
1034 nucleotides was amplified with the primers bdbAbk1
(gta ttc tat atg att aat tag cta act agt ATG AAA
CTG AGT GAT ATT TAT TTG G) and bdbAbk2 (CAA AAT TGC
AGA TCT AAA GTA ATC AAC). The resulting plasmid, pORIbdbA, was first inserted into the chromosome of B. subtilis 168 by a Campbell-type integration. Upon growth in the
absence of erythromycin, B. subtilis
bdbA was
obtained due to the spontaneous excision of the plasmid from the
chromosome together with the bdbA gene. Correct integration
and excision was verified by Southern hybridization. Note that the
bdbA deletion is designed in such a way that the
sunT gene remains intact despite the fact that these genes
overlap with four nucleotides.
bdbAs+,
the carboxyl-terminal part of the sunT gene was amplified
with the oligonucleotides sunTrec1 (cgc aca agc tTG TAG CAA
AGG CAG TTA TTA GC) and sunTrec2 (CAA TCC gga tcc TCA TAT
AGA ATA CTC CTT ATT TTC CG) and ligated into pMutin2 to construct the
plasmid pMsunTrec. pMsunTrec was integrated into the chromosome of
B. subtilis at the sunT locus by a Campbell-type integration (single crossover) resulting in B. subtilis
bdbAs+.
SP
as indicator strain. This
strain was constructed using the sequences with the NCBI accession
numbers M81760 and M81762 as described by Lazarevic et al.
(22). SP
-cured B. subtilis strains were previously shown
to be sensitive to a bacteriocin (betacin) specified by this prophage
(23). Sequencing of the SP
region of the B. subtilis 168 chromosome indicated that this bacteriocin is specified by a gene
(yolG; Ref. 22), which is now known as the gene for sublancin 168 (sunA). Thus, the SP
-cured strain lacks the
sunA gene and the as yet unidentified sublancin 168 resistance gene(s). The indicator strain and the mutant strains were
grown overnight on TY with the appropriate antibiotic(s). The overnight
culture of the indicator strain was then diluted 100-fold in TY, and
100 µl was subsequently plated. After drying the plate, 1-µl
aliquots of the overnight cultures of the relevant mutant strains were spotted, and the plates were incubated overnight. The next day plates
were analyzed for halo formation. In this assay, the presence of
antibiotics in the overnight cultures did not result in halo formation.
Importantly variations in the halo size of different colonies of the
same strain were insignificant, in particular when these colonies were
present on one plate.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-galactopyranoside-inducible
Pspac promoter (Fig.
3). Aliquots of an overnight culture of
B. subtilis sunT were spotted on a plate with the sublancin
168-sensitive indicator strain B. subtilis
SP
. It was
found that B. subtilis sunT completely lacked sublancin 168 activity (Fig. 4) also after induction of bdbA,
yolJ, and bdbB transcription by the addition of
isopropyl-1-thio-
-D-galactopyranoside (data not shown).
The latter observation shows that the lack of sublancin 168 production is not caused by a polar effect on the transcription of the genes located downstream of sunT. Taken together these results
demonstrate that SunT is essential for the production of active
sublancin 168. In what follows, this
conclusion is corroborated by mass spectrometry.

View larger version (11K):
[in a new window]
Fig. 3.
Schematic representation of the relative
locations of sunT and bdbA in
B. subtilis 168 (top) and B. subtilis sunT (bottom). The
Campbell-type integration (single crossover) of pMutin2 leads to the
disruption of the 3' end of the sunT gene. Simultaneously
the bdbA gene is placed under the transcriptional control of
the Pspac promoter. The relative locations of
the overlapping start (ATG) and stop (TGA) codons of bdbA
and sunT, respectively, are marked. The 3'
(sunT') and 5' ('sunT) truncated copies of
sunT are indicated.

View larger version (35K):
[in a new window]
Fig. 4.
Sublancin 168 production in B. subtilis 168 and a sunT mutant. From a
100-fold-diluted overnight culture of the B. subtilis
SP
indicator strain, 100 µl was plated. After drying of the
plate, 1-µl aliquots of overnight cultures of the strains to be
tested for sublancin 168 production were spotted, and subsequently the
plates were incubated overnight at 37 °C. Sublancin 168 activity is
visualized by halo formation.
SP
indicator strain was performed as
described above. Indeed, B. subtilis bdbB showed a
significantly decreased cell killing activity compared with the
parental strain 168, indicating that BdbB is involved in the production
of sublancin 168 (Fig. 5). The effect of
the bdbB mutation was particularly evident when the cells
were grown in the presence of 1% xylose, which is in accord with the
observation that xylose affects sublancin 168 production or activity
already in the parental strain (Fig. 5, compare the halo size of
B. subtilis 168 in the presence and absence of xylose). To
determine whether the decreased sublancin 168 activity in B. subtilis bdbB was a direct consequence of the disruption of
bdbB, we constructed B. subtilis
bdbB-XbdbB, in which the bdbB gene is
ectopically expressed from a xylose-inducible promoter. As shown in
Fig. 5, the ectopically expressed bdbB gene fully restored
the production of active sublancin 168 in the presence of xylose. Thus,
BdbB is important but not essential for the production of sublancin
168.

View larger version (43K):
[in a new window]
Fig. 5.
Sublancin 168 production in B. subtilis 168, B. subtilis bdbB, and
B. subtilis bdbB-XbdbB. In the
latter strain, the ectopic expression of the bdbB gene is
controlled by a xylose-inducible promoter. TY plates used in the
lower panels were supplemented with 1% xylose. Sublancin
168 production was tested as described in Fig. 4.

View larger version (26K):
[in a new window]
Fig. 6.
Sublancin 168 production in B. subtilis 168 and bdbB, bdbC
single and double mutant strains. Sublancin 168 production
was tested as described in Fig. 4.
bdbAs+ was restored. This was indeed the case
as depicted in Fig. 7. The observed sublancin 168 production by this
strain, which lacks bdbA, implies that BdbA is dispensable
for the production of this lantibiotic.

View larger version (24K):
[in a new window]
Fig. 7.
Sublancin 168 production in B. subtilis
bdbA and B. subtilis
bdbAs+. Sublancin 168 production was tested as described in Fig. 4.

View larger version (24K):
[in a new window]
Fig. 8.
Mass spectrometric analysis of subtilosin and
sublancin 168 production in different B. subtilis
strains. The peak cluster at m/z 3400 accounts for the proton-adduct [M + H]+
(m/z 3403.3, average mass) and alkali-adducts of
subtilosin (30). The signal observed at m/z
3881.2 is in accordance with the proton adduct of sublancin 168 (average mass).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (12K):
[in a new window]
Fig. 9.
Predicted membrane topology of SunT and
comparison with the model proposed by Franke et al.
(36) for the structurally related LcnC protein. Stars
(*) indicate the relative location of the 10 cysteines in SunT.
I-VI, hydrophobic domains I-VI; N, amino
terminus; C, carboxyl terminus.
prophage is required for immunity
against sublancin 168, it is presently not known how this immunity is
acquired. In general, two distinct systems for immunity against
bacteriocins have been described. The first makes use of dedicated
"immunity" proteins, small proteins that are weakly associated with
the outer surface of the cytoplasmic membrane thereby preventing pore
formation (11, 37, 38). The second is constituted of ATP-binding
cassette transporters (39-41). In this light, SunT could represent a
sublancin 168 immunity system that actively prevents the accumulation
of this lantibiotic in the membrane (22). However, our preliminary data
show that the sunT mutant used in the present studies is
resistant against sublancin 168, which suggests that SunT is not
involved. Likewise, BdbA, BdbB, and BdbC are not required for immunity
(data not shown).
bdbAS+ strain did not affect the production
of active sublancin 168. This is remarkable because BdbA is the
equivalent of Bdb of B. brevis, which can replace the major
oxidase DsbA of E. coli (16). The fact that BdbA is
dispensable for sublancin production does not exclude its possible
involvement in this process. For example, another as yet unidentified
thiol-disulfide oxidoreductase might complement for the absence of
BdbA, similar to what we have shown for BdbC. One of the candidates
could be BdbD, which cooperates with BdbC in competence development
(42). Both proteins, which are encoded by the bicistronic
bdbDC operon, are required for the folding of ComGC most
likely because this component of the DNA uptake machinery contains an
intramolecular disulfide bond, which is essential for its role in
competence (43).
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES

To whom correspondence should be addressed. Tel.:
31-50-363-3079; Fax: 31-50-363-3000; E-mail:
W.J.Quax@farm.rug.nl.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Tjalsma, H.,
Bolhuis, A.,
Jongbloed, J. D.,
Bron, S.,
and van Dijl, J. M.
(2000)
Microbiol. Mol. Biol. Rev.
64,
515-547 2.
Sonenshein, A. L.,
Hoch, J. A.,
and Losick, R.
(2001)
Bacillus subtilis and Its Closest Relatives
, 1st Ed.
, ASM Press, Washington, D. C.
3.
McAuliffe, O.,
Ross, R. P.,
and Hill, C.
(2001)
FEMS Microbiol. Rev.
25,
285-308[CrossRef][Medline]
[Order article via Infotrieve] 4.
Sahl, H. G.,
and Bierbaum, G.
(1998)
Annu. Rev. Microbiol.
52,
41-79[CrossRef][Medline]
[Order article via Infotrieve] 5.
Jack, R. W.,
Tagg, J. R.,
and Ray, B.
(1995)
Microbiol. Rev.
59,
171-200 6.
Guder, A.,
Wiedemann, I.,
and Sahl, H. G.
(2000)
Biopolymers
55,
62-73[CrossRef][Medline]
[Order article via Infotrieve] 7.
Chung, Y. J.,
Steen, M. T.,
and Hansen, J. N.
(1992)
J. Bacteriol.
174,
1417-1422 8.
Kiesau, P.,
Eikmanns, U.,
Gutowski-Eckel, Z.,
Weber, S.,
Hammelmann, M.,
and Entian, K.-D.
(1997)
J. Bacteriol.
179,
1475-1481 9.
Paik, S. H.,
Chakicherla, A.,
and Hansen, J. N.
(1998)
J. Biol. Chem.
273,
23134-23142 10.
Stein, T.,
Borchert, S.,
Conrad, B.,
Feesche, J.,
Hofemeister, B.,
Hofemeister, J.,
and Entian, K.-D.
(2002)
J. Bacteriol.
184,
1703-1711 11.
Saris, P. E.,
Immonen, T.,
Reis, M.,
and Sahl, H. G.
(1996)
Antonie Leeuwenhoek
69,
151-159[CrossRef][Medline]
[Order article via Infotrieve] 12.
van der Meer, J. R.,
Rollema, H. S.,
Siezen, R. J.,
Beerthuyzen, M. M.,
Kuipers, O. P.,
and de Vos, W. M.
(1994)
J. Biol. Chem.
269,
3555-3562 13.
Chakicherla, A.,
and Hansen, J. N.
(1995)
J. Biol. Chem.
270,
23533-23539 14.
Ritz, D.,
and Beckwith, J.
(2001)
Annu. Rev. Microbiol.
55,
21-48[CrossRef][Medline]
[Order article via Infotrieve] 15.
Bolhuis, A.,
Venema, G.,
Quax, W. J.,
Bron, S.,
and van Dijl, J. M.
(1999)
J. Biol. Chem.
274,
24531-24538 16.
Ishihara, T.,
Tomita, H.,
Hasegawa, Y.,
Tsukagoshi, N.,
Yamagata, H.,
and Udaka, S.
(1995)
J. Bacteriol.
177,
745-749 17.
Bardwell, J. C.,
Lee, J. O.,
Jander, G.,
Martin, N.,
Belin, D.,
and Beckwith, J.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
1038-1042 18.
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratories, Cold Spring Harbor, NY
19.
Kunst, F.,
and Rapoport, G.
(1995)
J. Bacteriol.
177,
2403-2407 20.
Horton, R. M.,
Hunt, H. D., Ho, S. N.,
Pullen, J. K.,
and Pease, L. R.
(1989)
Gene (Amst.)
77,
61-68[CrossRef][Medline]
[Order article via Infotrieve] 21.
Leenhouts, K.,
Buist, G.,
Bolhuis, A.,
ten Berge, A.,
Kiel, J.,
Mierau, I.,
Dabrowska, M.,
Venema, G.,
and Kok, J.
(1996)
Mol. Gen. Genet.
253,
217-224[CrossRef][Medline]
[Order article via Infotrieve] 22.
Lazarevic, V.,
Dusterhoft, A.,
Soldo, B.,
Hilbert, H.,
Mauel, C.,
and Karamata, D.
(1999)
Microbiology
145,
1055-1067[Abstract] 23.
Hemphill, H. E.,
Gage, I.,
Zahler, S. A.,
and Korman, R. Z.
(1980)
Can. J. Microbiol.
26,
1328-1333[Medline]
[Order article via Infotrieve] 24.
Kussmann, M.,
Nordhoff, E.,
Rahbek-Nielsen, H.,
Haebel, S.,
Rossel-Larsen, M.,
Jakobsen, L.,
Gobom, J.,
Mirgorodskaya, E.,
Kroll-Kristensen, A.,
Palm, L.,
and Roepstorff, P.
(1997)
J. Mass Spectrom.
32,
593-601[CrossRef] 25.
Landry, F.,
Lombardo, C. R.,
and Smith, J. W.
(2000)
Anal. Biochem.
279,
1-8[CrossRef][Medline]
[Order article via Infotrieve] 26.
Altschul, S. F.,
Madden, T. L.,
Schaffer, A. A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402 27.
Moller, S.,
Croning, M. D.,
and Apweiler, R.
(2001)
Bioinformatics
17,
646-653 28.
Zheng, G.,
Hehn, R.,
and Zuber, P.
(2000)
J. Bacteriol.
182,
3266-3273 29.
Babasaki, K.,
Takao, T.,
Shimonishi, Y.,
and Kurahashi, K.
(1985)
J. Biochem. (Tokyo)
98,
585-603 30.
Marx, R.,
Stein, T.,
Entian, K.-D.,
and Glaser, S. J.
(2001)
J. Protein Chem.
20,
501-506[CrossRef][Medline]
[Order article via Infotrieve] 31.
Higgins, C. F.
(1992)
Annu. Rev. Cell Biol.
8,
67-113[CrossRef][Medline]
[Order article via Infotrieve] 32.
Fath, M. J.,
and Kolter, R.
(1993)
Microbiol. Rev.
57,
995-1017 33.
Walker, J. E.,
Saraste, M.,
Runswick, M. J.,
and Gay, N. J.
(1982)
EMBO J.
1,
945-951[Medline]
[Order article via Infotrieve] 34.
Fremaux, C.,
Hechard, Y.,
and Cenatiempo, Y.
(1995)
Microbiology
141,
1637-1645[Abstract] 35.
Stoddard, G. W.,
Petzel, J. P.,
van Belkum, M. J.,
Kok, J.,
and McKay, L. L.
(1992)
Appl. Environ. Microbiol.
58,
1952-1961 36.
Franke, C. M.,
Tiemersma, J.,
Venema, G.,
and Kok, J.
(1999)
J. Biol. Chem.
274,
8484-8490 37.
Siegers, K.,
and Entian, K.-D.
(1995)
Appl. Environ. Microbiol.
61,
1082-1089[Abstract] 38.
Kuipers, O. P.,
Beerthuyzen, M. M.,
Siezen, R. J.,
and de Vos, W. M.
(1993)
Eur. J. Biochem.
216,
281-291[Medline]
[Order article via Infotrieve] 39.
McLaughlin, R. E.,
Ferretti, J. J.,
and Hynes, W. L.
(1999)
FEMS Microbiol. Lett.
175,
171-177[CrossRef][Medline]
[Order article via Infotrieve] 40.
Peschel, A.,
and Gotz, F.
(1996)
J. Bacteriol.
178,
531-536 41.
Klein, C.,
and Entian, K.-D.
(1994)
Appl. Environ. Microbiol.
60,
2793-2801 42.
Meima, R.,
Eschevins, C.,
Fillinger, S.,
Bolhuis, A.,
Hamoen, L. W.,
Dorenbos, R.,
Quax, W. J.,
van Dijl, J. M.,
Provvedi, R.,
Chen, I.,
Dubnau, D.,
and Bron, S.
(2002)
J. Biol. Chem.
277,
6994-7001 43.
Chung, Y. S.,
Breidt, F.,
and Dubnau, D.
(1998)
Mol. Microbiol.
29,
905-913[CrossRef][Medline]
[Order article via Infotrieve] 44.
Norrander, J.,
Kempe, T.,
and Messing, J.
(1983)
Gene (Amst.)
26,
101-106[CrossRef][Medline]
[Order article via Infotrieve] 45.
Vagner, V.,
Dervyn, E.,
and Ehrlich, S. D.
(1998)
Microbiology
144,
3097-3104[Abstract] 46.
Kim, L.,
Mogk, A.,
and Schumann, W.
(1996)
Gene (Amst.)
181,
71-76[CrossRef][Medline]
[Order article via Infotrieve] 47.
Kunst, F.,
Ogasawara, N.,
Moszer, I.,
Albertini, A. M.,
Alloni, G.,
Azevedo, V.,
Bertero, M. G.,
Bessieres, P.,
Bolotin, A.,
Borchert, S.,
Borriss, R.,
Boursier, L.,
Brans, A.,
Braun, M.,
Brignell, S. C.,
Bron, S.,
Brouillet, S.,
Bruschi, C. V.,
Caldwell, B.,
Capuano, V.,
Carter, N. M.,
Choi, S. K.,
Codani, J. J.,
Connerton, I. F.,
and Danchin, A.
(1997)
Nature
390,
249-256[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. J. Dutton, D. Boyd, M. Berkmen, and J. Beckwith Bacterial species exhibit diversity in their mechanisms and capacity for protein disulfide bond formation PNAS, August 19, 2008; 105(33): 11933 - 11938. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fontaine and P. Hols The Inhibitory Spectrum of Thermophilin 9 from Streptococcus thermophilus LMD-9 Depends on the Production of Multiple Peptides and the Activity of BlpGSt, a Thiol-Disulfide Oxidase Appl. Envir. Microbiol., February 15, 2008; 74(4): 1102 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Heras, M. Kurz, R. Jarrott, S. R. Shouldice, P. Frei, G. Robin, M. Cemazar, L. Thony-Meyer, R. Glockshuber, and J. L. Martin Staphylococcus aureus DsbA Does Not Have a Destabilizing Disulfide: A NEW PARADIGM FOR BACTERIAL OXIDATIVE FOLDING J. Biol. Chem., February 15, 2008; 283(7): 4261 - 4271. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lewin, A. Crow, A. Oubrie, and N. E. Le Brun Molecular Basis for Specificity of the Extracytoplasmic Thioredoxin ResA J. Biol. Chem., November 17, 2006; 281(46): 35467 - 35477. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. McClerren, L. E. Cooper, C. Quan, P. M. Thomas, N. L. Kelleher, and W. A. van der Donk Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic PNAS, November 14, 2006; 103(46): 17243 - 17248. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Darmon, R. Dorenbos, J. Meens, R. Freudl, H. Antelmann, M. Hecker, O. P. Kuipers, S. Bron, W. J. Quax, J.-Y. F. Dubois, et al. A Disulfide Bond-Containing Alkaline Phosphatase Triggers a BdbC-Dependent Secretion Stress Response in Bacillus subtilis. Appl. Envir. Microbiol., November 1, 2006; 72(11): 6876 - 6885. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Albano, W. K. Smits, L. T. Y. Ho, B. Kraigher, I. Mandic-Mulec, O. P. Kuipers, and D. Dubnau The Rok Protein of Bacillus subtilis Represses Genes for Cell Surface and Extracellular Functions J. Bacteriol., March 15, 2005; 187(6): 2010 - 2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Erlendsson, M. Moller, and L. Hederstedt Bacillus subtilis StoA Is a Thiol-Disulfide Oxidoreductase Important for Spore Cortex Synthesis J. Bacteriol., September 15, 2004; 186(18): 6230 - 6238. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tjalsma, H. Antelmann, J. D.H. Jongbloed, P. G. Braun, E. Darmon, R. Dorenbos, J.-Y. F. Dubois, H. Westers, G. Zanen, W. J. Quax, et al. Proteomics of Protein Secretion by Bacillus subtilis: Separating the "Secrets" of the Secretome Microbiol. Mol. Biol. Rev., June 1, 2004; 68(2): 207 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Westers, R. Dorenbos, J. M. van Dijl, J. Kabel, T. Flanagan, K. M. Devine, F. Jude, S. J. Seror, A. C. Beekman, E. Darmon, et al. Genome Engineering Reveals Large Dispensable Regions in Bacillus subtilis Mol. Biol. Evol., December 1, 2003; 20(12): 2076 - 2090. [Abstract] [Full Text] [PDF] |
||||
| ||||||